VANI

Companies
NASDAQ
Vivani Medical Inc.
Health Care
Price Chart
Overview

About VANI

vivani leverages proprietary technologies to develop and commercialize drug and device implants, including its lead asset npm-119 (exenatide implant), which seeks to treat patients with chronic diseases with high unmet medical need.

Market Cap
$88.8M
Volume
82.9K
Avg. Volume
64.4K
P/E Ratio
-2.017857
Dividend Yield
0.00%
Employees
31.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.98
Moderate Correlation
Volatility
High (0.71)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VANI.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VANI shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$88.8M
Volume82.9K
P/E Ratio-2.02
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 14, 2024
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how VANI fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025